Plasmodium falciparum is a protozoan parasite that causes the most severe form of human malaria. Five other Plasmodium species can also infect humans — P. vivax, P. malariae, P. ovale curtisi, P. ovale wallikeri and P. knowlesi — but P. falciparum is the most prevalent Plasmodium species in the African region, where 90% of all malaria occurs, and it is this species that causes the great majority of malaria deaths. These were reported by the WHO at 438 000 in 2015 from an estimated 214 million cases; importantly, however, figures for the global burden of malaria tend to have wide margins of error due to poor and inaccurate reporting. In this Perspective, features of P. falciparum that are unique among human malaria parasites are highlighted, and current issues surrounding the control and treatment of this major human pathogen are discussed.
-
Cover Image
Cover Image
Trypanosoma brucei, the causative agent of African sleeping sickness. Among the parasitology topics covered in this issue are perspectives on various aspects of trypanosome biology: Kemmerling et al. (pages 573–577) look at the immune response against Trypanosoma cruzi in the human placenta, while Maya et al. (pages 579–584) discuss therapeutic strategies in chronic Chagas cardiomyopathy, which is caused by T. cruzi. In addition, McCulloch et al. (pages 585–592) and Ooi and Rudenko (pages 593–600) explore antigenic variation in trypanosomes. Image credit: Kateryna Kon (Shutterstock ID: 520410646).
Plasmodium falciparum
Roberto Docampo, Catherine J. Merrick; Plasmodium falciparum. Emerg Top Life Sci 22 December 2017; 1 (6): 517–523. doi: https://doi.org/10.1042/ETLS20170099
Download citation file: